Clinical trial / 2013
Green tea extract significantly reduced uterine fibroid volume and symptom severity while improving quality of life in women with symptomatic fibroids.
A randomized trial assigned 39 women with symptomatic uterine fibroids to receive 800 mg/day of green tea extract (45% EGCG) or placebo (800 mg brown rice) for 4 months. In the 33 completers, green tea extract (n = 22) significantly reduced total uterine fibroid volume by 32.6% (P = 0.0001), compared to a 24.3% increase in the placebo group (n = 11). EGCG treatment also significantly decreased fibroid symptom severity by 32.4% (P = 0.0001), improved quality of life by 18.53% (P = 0.01), improved anemia by 0.7 g/dL (P = 0.02), and reduced average blood loss from 71 to 45 mL/month (P = 0.001). No adverse effects or endometrial pathologies were observed.
- Study type
- Double-blinded, placebo-controlled randomized clinical trial
- Who was studied
- 39 reproductive-age women (aged 18-50 years) with symptomatic uterine fibroids (33 completed)
- What was measured
- Uterine fibroid volume, symptom severity, health-related quality-of-life, anemia, and blood loss
THE PAPER
Treatment of symptomatic uterine fibroids with green tea extract: a pilot randomized controlled clinical study.
Roshdy E, Rajaratnam V, Maitra S, Sabry M, Allah AS, Al-Hendy A. Int J Womens Health, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.